GCTK
Glucotrack, Inc.Company Information
- Company Name
- Glucotrack, Inc.
- CIK
- CIK0001506983
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- GCTK: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- GCTK
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-04-22
- Last sale
- —
- Shares purchased (TTM)
- 182,539.6
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 364,029
- Shares outstanding
- 5,009,085
- Ownership
- 7.27%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- -45.87%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 1 | 4 | 7 | 8 | 10 | 9 | 6 | 0 | 0 | 1 | 4 | 7 | ||||||
| Other Assets Current | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 1 | 4 | 8 | 8 | 10 | 9 | 6 | 1 | 0 | 2 | 5 | 7 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Restricted Cash Noncurrent | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 1 | 4 | 8 | 8 | 10 | 10 | 6 | 1 | 1 | 2 | 5 | 7 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 1 | 1 | 2 | 3 | 2 | 1 | 2 | 3 | 1 | 1 | 1 | ||||||
| Notes Payable Current | - | - | - | - | - | - | - | - | 0 | - | - | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Convertible Notes Payable Current | - | - | - | - | - | 0 | 0 | 0 | - | - | - | - | ||||||
| Derivative Liabilities | - | - | - | - | - | - | - | 0 | - | - | - | - | ||||||
| Other Notes Payable Current | 2 | 3 | 3 | 3 | - | - | - | - | - | - | - | - | ||||||
| Other Liabilities Current | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | ||||||
| Liabilities Current | 3 | 5 | 5 | 5 | 3 | 2 | 1 | 5 | 4 | 1 | 2 | 1 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Derivative Liabilities Noncurrent | - | - | 0 | 0 | 0 | 0 | 17 | - | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Other Liabilities Noncurrent | - | - | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Noncurrent | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Long Term Loans Payable | 0 | 0 | - | 0 | 0 | 0 | - | - | - | - | - | - | ||||||
| Liabilities | 3 | 5 | 5 | 6 | 3 | 2 | 19 | 5 | 4 | 2 | 2 | 2 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 158 | 155 | 151 | 151 | 151 | 146 | 119 | 118 | 114 | 113 | 113 | 113 | ||||||
Stockholders Equity | ||||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Retained Earnings Accumulated Deficit | -160 | -156 | -152 | -148 | -144 | -139 | -132 | -122 | -117 | -113 | -110 | -107 | ||||||
| Stockholders Equity | -2 | -1 | 3 | 3 | 7 | 7 | -13 | -4 | -3 | 0 | 3 | 6 | ||||||
| Liabilities And Stockholders Equity | 1 | 4 | 8 | 8 | 10 | 10 | 6 | 1 | 1 | 2 | 5 | 7 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 250 | 250 | 250 | 250 | 250 | 250 | 100 | 100 | 100 | 500 | 100 | 500 | ||||||
| Common Stock Shares Issued | 6 | 3 | 1 | 1 | 1 | 26 | 13 | 6 | 5 | 27 | 0 | 21 | ||||||
| Shares Outstanding | 6 | 3 | 1 | 1 | 1 | 26 | 13 | 6 | 5 | 27 | 0 | 21 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialGlucotrack, Inc. (GCTK) — SEC Financial Statements & Analysis
Glucotrack, Inc. (GCTK) is a surgical & medical instruments & apparatus company, incorporated in DE. Glucotrack, Inc. trades on Nasdaq as: GCTK. Glucotrack, Inc. (GCTK)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, Glucotrack, Inc. carries a market cap of $23.97M, a P/E ratio of 1.50x, a P/B ratio of -13.77x, an enterprise value of $22.84M, and an EV/EBITDA multiple of 1.48x. On profitability, it posts a Return on Equity (ROE) of 620.63% and a Return on Assets (ROA) of 272.48%. Per share, it reports EPS of $3.18, diluted EPS of $3.18, free cash flow per share of $-3.26, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -40.43% year-over-year and EPS growth of -94.12% year-over-year. On the balance sheet, it maintains a current ratio of 0.46x, a quick ratio of 0.46x, working capital of $-1.61M, a debt-to-equity ratio of -1.86x, a debt ratio of 2.16, free cash flow of $-16.31M (TTM), and net debt of $-1.12M. Figures sourced from SEC EDGAR.
- Market Cap
- $23.97M
- P/E TTM
- 1.50x
- EPS TTM
- $3.18
- P/B TTM
- -13.77x
- ROE TTM
- 620.63%
- ROA TTM
- 272.48%
- Debt To Equity
- -1.86x
- Free Cash Flow TTM
- $-16.31M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Glucotrack, Inc. in?
Glucotrack, Inc. (GCTK) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does GCTK trade on?
Glucotrack, Inc. (GCTK) trades on the Nasdaq.
Where is Glucotrack, Inc. incorporated?
Glucotrack, Inc. is incorporated in DE.
When was Glucotrack, Inc. (GCTK)'s most recent SEC filing?
Glucotrack, Inc. (GCTK)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is GCTK's market cap?
Glucotrack, Inc. (GCTK) has a market capitalization of $23.97M as of 2026-06-30.
What is GCTK's P/E ratio?
Glucotrack, Inc. (GCTK)'s trailing twelve month P/E ratio is 1.50x as of 2026-06-30.
What is GCTK's EPS (earnings per share)?
Glucotrack, Inc. (GCTK)'s trailing twelve month EPS is $3.18 as of 2026-06-30.
What is GCTK's ROE (return on equity)?
Glucotrack, Inc. (GCTK)'s trailing twelve month Return on Equity (ROE) is 620.63% as of 2026-06-30.
What is GCTK's ROA (return on assets)?
Glucotrack, Inc. (GCTK)'s trailing twelve month Return on Assets (ROA) is 272.48% as of 2026-06-30.
What is GCTK's EV/EBITDA?
Glucotrack, Inc. (GCTK)'s trailing twelve month EV/EBITDA is 1.48x as of 2026-06-30.